Thuy A. Tran, MSc Pharm, PhD, Associate professor
Thuy A. Tran, MSc Pharm, PhD, Associate professor
Team leader Dept Oncology and Pathology & Head of R&D of Karolinska Radiopharmacy
Verified email at - Homepage
Cited by
Cited by
Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors
A Orlova, V Tolmachev, R Pehrson, M Lindborg, T Tran, M Sandstrom, ...
Cancer research 67 (5), 2178-2186, 2007
Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2: 2395, with C-terminally engineered cysteine
S Ahlgren, H Wållberg, TA Tran, C Widström, M Hjertman, L Abrahmsén, ...
Journal of Nuclear Medicine 50 (5), 781-789, 2009
99mTc-maEEE-ZHER2:342, an Affibody Molecule-Based Tracer for the Detection of HER2 Expression in Malignant Tumors
T Tran, T Engfeldt, A Orlova, M Sandström, J Feldwisch, L Abrahmsén, ...
Bioconjugate chemistry 18 (6), 1956-1964, 2007
Imaging of HER2-expressing tumours using a synthetic Affibody molecule containing the 99mTc-chelating mercaptoacetyl-glycyl-glycyl-glycyl (MAG3) sequence
T Engfeldt, A Orlova, T Tran, A Bruskin, C Widström, AE Karlström, ...
European journal of nuclear medicine and molecular imaging 34, 722-733, 2007
99mTc-chelator engineering to improve tumour targeting properties of a HER2-specific Affibody molecule
T Engfeldt, T Tran, A Orlova, C Widström, J Feldwisch, L Abrahmsen, ...
European journal of nuclear medicine and molecular imaging 34, 1843-1853, 2007
Tumor targeting using affibody molecules: interplay of affinity, target expression level, and binding site composition
V Tolmachev, TA Tran, D Rosik, A Sjöberg, L Abrahmsén, A Orlova
Journal of Nuclear Medicine 53 (6), 953-960, 2012
Development and preclinical characterisation of 99mTc-labelled Affibody molecules with reduced renal uptake
T Ekblad, T Tran, A Orlova, C Widström, J Feldwisch, L Abrahmsén, ...
European journal of nuclear medicine and molecular imaging 35, 2245-2255, 2008
Combined Magnetomotive ultrasound, PET/CT, and MR imaging of 68Ga-labelled superparamagnetic iron oxide nanoparticles in rat sentinel lymph nodes in vivo
M Evertsson, P Kjellman, M Cinthio, R Andersson, TA Tran, R in’t Zandt, ...
Scientific reports 7 (1), 4824, 2017
In Vivo Evaluation of Cysteine-Based Chelators for Attachment of 99mTc to Tumor-Targeting Affibody Molecules
T Tran, T Engfeldt, A Orlova, C Widström, A Bruskin, V Tolmachev, ...
Bioconjugate chemistry 18 (2), 549-558, 2007
68Ga-labeled superparamagnetic iron oxide nanoparticles (SPIONs) for multi-modality PET/MR/Cherenkov luminescence imaging of sentinel lymph nodes
R Madru, TA Tran, J Axelsson, C Ingvar, A Bibic, F Ståhlberg, L Knutsson, ...
American journal of nuclear medicine and molecular imaging 4 (1), 60, 2014
Nuclear localization of cell-penetrating peptides is dependent on endocytosis rather than cytosolic delivery in CHO cells
JL Zaro, JE Vekich, T Tran, WC Shen
Molecular pharmaceutics 6 (2), 337-344, 2009
Effects of Lysine-Containing Mercaptoacetyl-Based Chelators on the Biodistribution of 99mTc-Labeled Anti-HER2 Affibody Molecules
TA Tran, T Ekblad, A Orlova, M Sandstrom, J Feldwisch, A Wennborg, ...
Bioconjugate chemistry 19 (12), 2568-2576, 2008
Design, synthesis and biological evaluation of a multifunctional HER2-specific Affibody molecule for molecular imaging
TA Tran, D Rosik, L Abrahmsén, M Sandström, A Sjöberg, H Wållberg, ...
European journal of nuclear medicine and molecular imaging 36, 1864-1873, 2009
Pre-clinical evaluation of [111In]-benzyl-DOTA-ZHER2: 342, a potential agent for imaging of HER2 expression in malignant tumors
A Orlova, T Tran, C Widström, T Engfeldt, A Eriksson Karlström, ...
International journal of molecular medicine 20 (3), 397-404, 2007
186Re-maSGS-ZHER2:342, a potential Affibody conjugate for systemic therapy of HER2-expressing tumours
A Orlova, TA Tran, T Ekblad, AE Karlström, V Tolmachev
European journal of nuclear medicine and molecular imaging 37, 260-269, 2010
Protection of Kidney Function with Human Antioxidation Protein α1-Microglobulin in a Mouse 177Lu-DOTATATE Radiation Therapy Model
A Kristiansson, J Ahlstedt, B Holmqvist, A Brinte, TA Tran, ...
Antioxidants & redox signaling 30 (14), 1746-1759, 2019
135La as an Auger-electron emitter for targeted internal radiotherapy
J Fonslet, BQ Lee, TA Tran, M Siragusa, M Jensen, T Kibedi, ...
Physics in Medicine & Biology 63 (1), 015026, 2017
Biodistribution and pharmacokinetics of recombinant α1-microglobulin and its potential use in radioprotection of kidneys
J Ahlstedt, TA Tran, F Strand, B Holmqvist, SE Strand, M Gram, ...
American journal of nuclear medicine and molecular imaging 5 (4), 333, 2015
Human anti-oxidation protein A1M—a potential kidney protection agent in peptide receptor radionuclide therapy
J Ahlstedt, TA Tran, SE Strand, M Gram, B Åkerström
International journal of molecular sciences 16 (12), 30309-30320, 2015
Preclinical efficacy of hK2 targeted [177Lu] hu11B6 for prostate cancer theranostics
OV Timmermand, J Elgqvist, KA Beattie, A Örbom, E Larsson, SE Eriksson, ...
Theranostics 9 (8), 2129, 2019
The system can't perform the operation now. Try again later.
Articles 1–20